The authors created a useful collection of Rep protein variants with changes that alter the amino acid sequence, but these did not lead to clear improvements in how the virus worked. Instead, their ...

TuHURA Biosciences targets immunotherapy resistance, a key unmet need, with promising early data. Click here to find out why ...

Explore the importance of GMP-grade plasmid DNA (pDNA) in cell and gene therapies, the challenges in global supply, and how ...

4basebio reported strong progress for the year ended 31 December on Tuesday, with revenue doubling from DNA sales to £0.93m ...

The Board of 4basebio plc is pleased to report the results for the financial year ended 31 December 2024. The annual report and accounts together with a notice of the Company’s annual general meeting, ...

GenScript, a global leader in life science research tools and services support, has expanded its mRNA synthesis and ...

Thermo Fisher Scientific has introduced the Applied Biosystems™ MagMAX™ Pro HT NoSpin Plasmid MiniPrep Kit to meet the ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving ...

Results further validate PlaCCine as a novel vaccine platform with potential applications in COVID-19 and other infectious diseases with epidemic implications “It is very encouraging to see strong ...

Provides ReciBioPharm's customers with access to NewBiologix's Xcell-Eng-HEK293 cell lines for advanced therapies <l ...

The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a market size of USD 24.6 Billion by 2032 growing at a CAGR of 18.5% from ...

Plasmid DNA (pDNA) has become a cornerstone in the development of advanced therapeutics, including gene therapies, DNA vaccines, and cell-based treatments. The escalating demand for these innovative ...